In a groundbreaking achievement for genomic science, researchers at the University of the Witwatersrand (Wits) in South Africa have spearheaded the AGenDA project, successfully sequencing and adding more than 1,000 new whole-genome sequences from diverse African populations to international databases. This milestone, detailed in a peer-reviewed paper published in Nature on January 14, 2026 (DOI: 10.1038/s41586-025-09935-7), marks a significant step toward correcting longstanding underrepresentation of African genetic data in global research. Led by the Sydney Brenner Institute for Molecular Bioscience (SBIMB) at Wits, the Assessing Genetic Diversity in Africa (AGenDA) initiative promises to uncover millions of novel genetic variants, potentially revolutionizing disease risk prediction and personalized medicine worldwide.

The project addresses a critical gap: despite Africa being the cradle of humankind with the highest genetic diversity on the planet—where two individuals from different African regions can be more genetically distinct than a European and an Asian—less than 2% of sequenced human genomes originate from African ancestry. This Eurocentric bias in datasets has led to inaccurate polygenic risk scores and genome-wide association studies (GWAS) that perform poorly for African populations, limiting the effectiveness of precision medicine on the continent and beyond.

Unveiling the AGenDA Project: Scope and Methodology

The AGenDA project, coordinated from South Africa but spanning eight other African nations, meticulously selected participants from underrepresented ethnolinguistic and geographic groups. Whole-genome sequencing—analyzing the entire DNA sequence of an individual rather than targeted panels—was employed to generate comprehensive reference data. This approach captures the full spectrum of genetic variation, including rare variants that smaller studies might miss.

Sampling occurred in Angola, the Democratic Republic of Congo, Kenya, Libya, Mauritius, Rwanda, Tunisia, and Zimbabwe. Targeted populations included hunter-gatherer communities with Khoe-San ancestry, Nilo-Saharan and Afro-Asiatic speakers, understudied Bantu-speaking (Niger-Congo) groups, North Africans, and Indian Ocean islanders. These choices filled key gaps in existing databases, which often overlook North Africa and certain linguistic isolates.

• Hunter-gatherers: Represent ancient lineages with unique adaptations.
• Nilo-Saharan speakers: From pastoralist groups in East and Central Africa.
• Afro-Asiatic speakers: Including Berber and Cushitic peoples in North Africa.
• Bantu subgroups: Understudied variants within expansive Niger-Congo branch.
• Island populations: Genetic isolates from Mauritius offering admixture insights.

This strategic selection ensures the dataset's utility for tracing human migration, admixture events, and evolutionary responses to pathogens and environments unique to Africa.

The Critical Issue of Underrepresentation in Global Genomics

Global genomic databases like the 1000 Genomes Project and UK Biobank are overwhelmingly populated by European-descent data—over 86% of studies as of recent analyses. Africa's over 2,000 ethnolinguistic groups embody the deepest branches of human genetic history, yet this diversity is scarcely captured. Prof. Michèle Ramsay, SBIMB Director and lead author, notes: "Most genomic datasets used to predict disease risk come from people of European origin, resulting in very Eurocentric patterns that poorly predict diseases in African populations."

Consequences are profound: GWAS identify fewer variants in non-European cohorts, leading to underpowered risk models for conditions like diabetes, hypertension, and cancer prevalent in Africa. For instance, cardiometabolic diseases, studied via Wits' prior AWI-Gen project, show environment-gene interactions best revealed through diverse genomes.

For academics and researchers eyeing opportunities in this field, platforms like AcademicJobs.com research jobs list openings in genomics and bioinformatics at institutions like Wits.

Key Architects: Wits Researchers Driving Change

At the helm is Prof. Michèle Ramsay, a genomic scientist championing African-led research. Dr. Furahini Tluway, AGenDA Coordinator, oversaw logistics and community engagement. Prof. Scott Hazelhurst heads bioinformatics, ensuring data quality for downstream analyses, while Dr. Ananyo Choudhury co-led population selection to maximize diversity.

SBIMB, named after Nobel laureate Sydney Brenner, is a hub for molecular bioscience, fostering multidisciplinary teams. Their work exemplifies higher education's role in global science, training PhDs and postdocs—career paths accessible via postdoc positions on AcademicJobs.com.

Governance and Ethics: A Model for African-Led Science

AGenDA stands out for its ethical framework: African scientists govern data access via continent-based committees, reviewing requests for purpose and benefit-sharing. Community engagement preceded sampling, with informed consent in local languages and culturally adapted processes, countering historical exploitation like the Hottentot Venus case.

Data is deposited in the European Genome-phenome Archive (EGA) and accessible through the Global Alliance for Genomics and Health (GA4GH), prioritizing African researchers.

Read the full Wits announcement.

Building on H3Africa: A Decade of Pan-African Genomics

AGenDA extends the Human Heredity and Health in Africa (H3Africa) consortium, launched in 2010 with NIH and Wellcome Trust support. H3Africa has trained over 480 PhDs, sequenced thousands of genomes, and birthed projects like AWI-Gen—co-led by Wits—which genotyped 12,000+ for cardiometabolic traits.

AWI-Gen revealed novel variants for hypertension and obesity, underscoring Africa's unique gene-environment dynamics. For those pursuing genomics careers, craft a standout academic CV to join such initiatives.

Transformative Impacts on Precision Medicine

Expected outcomes include millions of novel variants, enhancing GWAS power. African data distinguishes ancient from recent mutations, refining causality in disease genes. For heart disease—killing millions in Africa annually—better risk scores could guide interventions.

• Improved polygenic risk scores for diabetes, reducing misdiagnosis.
• Tailored cancer therapies accounting for African-specific mutations.
• Enhanced mental health genomics, addressing stigma-laden conditions.
• Pharmacogenomics for drug responses, minimizing adverse effects.

Globally, it bolsters AI models for diagnostics, as Ramsay warns: "If we don’t feed AI with African data, outputs will be biased."

Challenges Overcome and Lessons Learned

Navigating diverse ethics boards, legal frameworks, and logistics across nine countries was daunting. Yet, co-creation with local partners ensured relevance. Budget constraints limited scale—covering all 2,000+ groups would need hundreds of thousands of genomes—but AGenDA prioritizes depth over breadth.

For aspiring researchers, free resume templates on AcademicJobs.com aid applications to similar projects.

Future Horizons: Scaling African Genomics

Next steps: Integrate AGenDA data into reference panels, launch follow-up sequencing, and expand to pharmacogenomics. H3Africa eyes 3 million genomes continent-wide. This positions Wits as a leader, attracting funding and talent.

Stakeholders—from governments to pharma—must invest in infrastructure. For professionals, explore research assistant jobs or lecturer positions in South African universities via AcademicJobs.com.

Career Opportunities in Genomics at South African Universities

This milestone underscores booming demand for bioinformaticians, geneticists, and ethicists. Wits and peers seek postdocs for variant analysis and cohort studies. South Africa higher ed jobs abound, with salaries competitive amid research grants.

Advice: Build skills in tools like GATK for sequencing, R for stats. Network via H3Africa events. Rate professors on RateMyProfessor for insights into programs.

Conclusion: A Leap for Equitable Science

The Wits-led AGenDA study not only enriches global science but empowers Africa in precision medicine. By prioritizing diversity, ethics, and leadership, it sets a blueprint for inclusive research. Explore careers at higher ed jobs, seek advice on career advice, or browse university jobs. Share your thoughts in comments below.

For more, visit PubMed abstract. Business Day coverage.